In a welcome move, Cigna Group saw its Relative Strength Rating rise from 64 to 74 on Wednesday.
This proprietary rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating of above 80 as they begin their largest runs. See if Cigna Group can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Cigna Group is building a cup without handle with a 370.82 buy point. See if the stock can break out in heavy trading.
The company reported -2% EPS growth in the latest quarterly report. Sales increased 28%.
Cigna Group earns the No. 1 rank among its peers in the Medical-Managed Care industry group. Alignment Healthcare and UnitedHealth Group are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
